Saluda Medical sees FY27 revenue growth 25%-35% vs FY26
Saluda Medical expects FY27 revenue to grow between 25% and 35% versus FY26.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Saluda Medical expects FY27 revenue to grow between 25% and 35% versus FY26.